# Elea.ai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/elea-ai

- Industry: Healthcare IT
- Headquarters: Hamburg, Germany
- Website: www.elea.health/
- Total disclosed funding: $4.3M
- Latest round: Seed (Feb 25, 2024)
- Investors on record: 4

## About

Elea.ai GmbH specializes in AI-driven pathology information systems, enhancing efficiency in pathology laboratories through automation and deep learning technology.Elea.ai GmbH, founded in 2024 in Hamburg, Germany, focuses on providing an advanced pathology information system. The company raised EUR 4 million in Seed funding on February 25, 2024, led by Fly Ventures and Giant Ventures, among others. The founder's previous entrepreneurial history is not publicly detailed.elea offers an advanced AI-driven pathology information system designed to streamline and enhance the workflow within pathology laboratories. Its core product, known as elea Pathology OS, integrates deep learning technologies and automation to significantly increase throughput while reducing case processing times by up to 50%. The system facilitates seamless data management, enabling pathologists to focus on diagnostic evaluations while automating data extraction and report generation. This technology addresses challenges such as delays in diagnostics, error reduction in reporting, and improved patient outcomes, making it a vital tool for hospitals and diagnostic laboratories. elea’s products are implemented across various international markets, including Europe and North America, where healthcare providers benefit from improved efficiency and precision in pathology diagnostics.Revenue generation for elea is structured primarily through a subscription model for its software services, allowing laboratories and hospitals to access the elea Pathology OS while benefiting from ongoing updates and support. Transactions typically occur between elea and medical institutions, where the software is licensed on an annual basis, enhancing laboratory operations and data management capabilities. In addition, the system supports various medical communication protocols, enabling seamless integration into existing hospital infrastructures. While specific pricing details for subscriptions and services are not disclosed, the robust capabilities of elea’s offerings suggest a value proposition aimed at substantial operational savings and increased productivity for users in the healthcare sector.In February 2024, Elea.ai GmbH raised EUR 4 million in Seed funding, which will be utilized to scale and expand into new departments, starting with pathology. The company plans to design and launch upcoming products that will further enhance its offerings in the pathology space. Elea.ai GmbH aims to penetrate additional markets, with specific goals of expanding its reach into new geographic regions, although exact locations and timelines have not been disclosed.

## Funding rounds

- Seed, Feb 25, 2024, $4.3M — Innovationsstarter Fonds Hamburg, MVZ Leverkusen, Fly Ventures, Giant Ventures

## Investors

- Innovationsstarter Fonds Hamburg (https://capitalatlas.ai/funds/innovationsstarter-fonds-hamburg) — Seed
- MVZ Leverkusen — Seed
- Fly Ventures (https://capitalatlas.ai/funds/fly-ventures) — Seed
- Giant Ventures (https://capitalatlas.ai/funds/giant-ventures) — Seed